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ABSTRACT 
 
Object: To enhance detection of the products of hyperpolarized [2-13C]dihydroxyacetone metabolism for 
assessment of three metabolic pathways in the liver in vivo. Hyperpolarized [2-13C] DHAc emerged as a 
promising substrate to follow gluconeogenesis, glycolysis and the glycerol pathways. However, the use of 
[2-13C]DHAc in vivo has not taken off because (i) the chemical shift range of [2-13C]DHAc and its metabolic 
products span over 144 ppm and (ii) 1H decoupling is required to increase spectral resolution and sensitivity. 
While these issues are trivial for high-field vertical-bore NMR spectrometers, horizontal-bore small-animal 
MR scanner are seldom equipped for such experiments.  
 
Methods: Real-time hepatic metabolism of three fed mice was probed by 1H-decoupled 13C-MR following 
injection of hyperpolarized [2-13C]DHAc. The spectra of [2-13C]DHAc and its metabolic products were 
acquired in a 7 T small-animal MR scanner using three purpose-designed spectral-spatial radiofrequency 
pulses that excited a spatial bandwidth of 8 mm with varying spectral bandwidths and central frequencies 
(chemical shifts). 
 
Results: The metabolic products detected in vivo include glycerol 3-phosphate, glycerol, 
phosphoenolpyruvate, lactate, alanine, glyceraldehyde 3-phosphate and glucose 6-phosphate. The 
metabolite-to-substrate ratios were comparable to those reported previously in perfused liver. 
 
Discussion: Three metabolic pathways can be probed simultaneously, in real-time in the mouse liver in 
vivo using hyperpolarized DHAc. 
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MANUSCRIPT BODY 
 
INTRODUCTION  
The human liver performs a broad range of tasks that affect the function of the whole body, from maintaining 
plasma glucose homeostasis to filtering toxic chemicals from food and drinks [1]. In most cases, the liver 
can regenerate after an insult and recover functionality. However, recurrent damage to the liver may result 
in permanent loss of liver mass, with potentially fatal consequences.  
Magnetic resonance (MR) could play an important role in the identification of biomarkers to assess 
metabolic function of the liver in situ and non-invasively. For example, multiparametric 1H-MR has already 
proven to be a valuable tool to stratify NAFLD patients [2],[3], and MRI-estimated proton density fat fraction 
and MR elastography allow quantification of hepatic steatosis and fibrosis, respectively [4].  In 13C-MR, 
resonances are widely dispersed over a chemical shift range of ~200 ppm, and multiple metabolites can 
easily be distinguished. However, the clinical value of 13C-MR has been limited by its intrinsically low 
sensitivity compared to 1H-MR due to 1) its low natural abundance, 2) lower nuclear polarization, a 
consequence of the 4 times lower gyromagnetic ratio of the carbon-13 nucleus, and, where molecularly 
relevant, 3) splitting of the 13C resonances due to spin-spin coupling with protons. The first two limitations 
may be overcome by injecting hyperpolarized (HP) 13C-labeled molecules, which transiently boost the 13C-
MR signal. The third limitation can be resolved with 1H decoupling during 13C signal reception.  
HP-MR by dissolution Dynamic Nuclear Polarization (DNP) is an emerging technique that increases 
the sensitivity of the MR signal by 50.000-fold. A single DNP shot (~seconds) can provide a signal-to-noise 
ratio (SNR) that is not accessible by any conventional MR acquisition. Consequently, this hyper-intense 
signal can be used to measure rapid metabolic processes such as enzymatic reactions and transient 
metabolic reaction intermediates in vivo, in situ and non-invasively with high temporal resolution. DNP-MR 
can provide information on the mechanistic and biochemical changes that occur in the diseased organ [5]. 
Multiple HP 13C-labeled substrates have provided insights into several metabolic pathways, including 
glycolysis, the pentose-phosphate pathway and cellular redox state [6],[7]. And strategies are being 
explored to increase organ selectivity by suppressing the signal arising from specific cell types [8].  HP 
[1-13C]pyruvate has been used extensively in preclinical studies of cancer, cardiovascular diseases and 
diabetes, and has already been translated into a clinical setting [7],[9]. Another HP probe, 
[2-13C]dihydroxyacetone (DHAc), has recently been shown to report on glucose metabolism in the liver 
[10],[11] and could potentially be used to investigate the dysregulation of hepatic gluconeogenesis (GNG) 
and glycolysis in metabolic diseases such as NAFLD [12]. HP [U-2H,13C]glucose has also been used 
successfully for in vivo metabolic studies [13],[14]. However, with current experimental setups, the loss of 
13C polarization during transport (3-15 s) and substrate delivery to the organ of interest (~10s) is far less for 
[2-13C]DHAc (T1~40 s) than for [U-2H,13C]glucose (T1<15 s), making DHAc a superior probe for sampling 
GNG and glycolysis in vivo. 
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Upon injection, DHAc is rapidly converted into dihydroxyacetone phosphate (DHAP) and enters the 
glycolytic, gluconeogenic and glycerol synthesis pathways.  This imaging agent probes the upper half of 
GNG as DHAP is converted to fructose-1,6-bisphosphate and on to glucose, potentially via glyceraldehyde-
3-phosphate (Ga3P). Similarly, DHAc probes the lower half of glycolysis as DHAP via Ga3P is converted 
to glycerate-1,3-bisphosphate. (Fig. 1). The oral and transdermal administration of DHAc has an 
exceptional safety profile, having been given as an oral metabolic challenge nearly a century ago [15], and 
currently being used as a tanning product [16]. In addition, DHAc has recently been hyperpolarized using 
photogenerated non-persistent radicals, which results in a solution of HP DHAc free of radicals without the 
need for filtration prior to injection into a patient [7]. Although DHAc has clinical translational potential, any 
eventual clinical translation would be dependent on phase-1 trials to ensure that the agent was safe for 
patients with compromised liver function. In perfused liver, 1H-decoupled 13C-MR spectra showed that 
[2-13C]DHAc metabolism could report on gluconeogenesis, glycolysis and glycerol synthesis pathways [10]. 
Such detail of metabolism has not previously been observed in vivo. An initial study using a 3 T clinical 
scanner in which 1H-decoupling was applied during non-selective, broadband pulse and acquire 13C-MR 
spectroscopy showed that 1H-decoupling increased the signal-to-noise ratio (SNR) of glycerol-3-phosphate 
(G3P) by 71%, albeit G3P was the only metabolite that could be detected apart from the injected HP 
[2-13C]DHAc and its hydrate [17]. The challenges inherent to in vivo 13C-MR experiments with HP 
[2-13C]DHAc are due to the large chemical shift range covered by the substrate and its products [18] (~144 
ppm or ~10.5 kHz at 7 T). These challenges include (i) requiring a spatial localisation by excitation to restrict 
signals to the tissue of interest and, at the same time, (ii) requiring a reduced excitation of the spectral 
bandwidth to avoid large chemical shift artefact that would be induced from a single 10.5 kHz bandwidth; 
(iii) excessive excitation of the HP sample magnetization, which shortens the time window for real-time 
metabolic fate observation. To mitigate these undesirable effects, algorithmically-generated RF pulses may 
be designed and used to excite MR signals with spectral and spatial (SPSP) control [11],[18].  A single 
SPSP RF pulse probing the entire spectral range covered by DHAc and its downstream products has been 
successfully implemented at 3 T (~4.6 kHz spectral bandwidth) [11],[18]. However, spectral constraints on 
pulse design favor SPSP RF control at narrow spectral bandwidths, and at higher magnetic fields SPSP 
selectivity is better controlled by multiple SPSP RF pulses applied sequentially [19]. 
Here we present a protocol that involves 1H-decoupled 13C-MR acquisitions using SPSP RF pulses for 
the detection of HP [2-13C]DHAc in the mouse liver in vivo at 7 T (~10.5 kHz spectral bandwidth) and the 
same metabolic products that were observed in the perfused mouse liver at 9.4 T [10] with comparable 
spectral resolution (linewidth < 20 Hz in vivo). The study was designed to enhance detection of the 
metabolic products of HP [2-13C]DHAc and to allow for simultaneous assessment of three metabolic 
pathways in the liver in vivo. 
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Fig. 1 Metabolism of dihydroxyacetone in the liver. Metabolites highlighted in either purple (glycerol 
synthesis) or yellow (gluconeogenesis/glycolysis) were observed in the present 13C-MR study. 
Abbreviations: DHAc = dihydroxyacetone, DHAP = dihydroxyacetone phosphate, G3P = glycerol-3-
phosphate, G6P = glucose-6-phosphate, Ga3P = glyceraldehyde 3-phosphate, PEP = 
phosphoenolpyruvate. 
 
EXPERIMENTAL 
Spectral-spatial (SPSP) RF pulse design 
Three SPSP RF pulses were designed using a MATLAB® software package available online 
(https://github.com/agentmess/Spectral-Spatial-RF-Pulse-Design) [20],[21] to excite a 8 mm thick slab with 
varying central frequencies and spectral bandwidths: ‘pulse #1’ was centered on the [2-13C]DHAc 
resonance (214 ppm, 250 Hz spectral passband, 1908 Hz spectral stop-band, 6757 Hz spatial bandwidth, 
10.44 ms), ‘pulse #2’ on the  phosphoenolpyruvate (PEP) resonance (150.5 ppm, 250 Hz spectral 
passband, 1724 Hz spectral stop-band, 7813 Hz spatial bandwidth, 10.18 ms), and ‘pulse #3’ was set to 
excite the other metabolites of interest (72 ppm and 50 ppm, 780 Hz spectral passband, 1634 Hz spectral 
stop-band, 8929 Hz spatial bandwidth, 2.98 ms). The RF pulses used a flyback design and were optimized 
to excite the frequencies of the resonances of interest while avoiding excitation of the other resonances by 
the periodic excitation bands. An extra gradient lobe was used to refocus spins across the spatial dimension 
and a maximum slew rate of 2x105 Gauss/cm/s (2000 T/m/s) and raster time of 4 µs were included as a 
constraint on the pulse design. 
 
Hyperpolarization of [2-13C]DHAc  
Hyperpolarized samples of [2-13C]DHAc were prepared as described previously [18]. Briefly, a stock 
solution of 8 M [2-13C]DHAc (Sigma-Aldrich, Haverhill, UK) and 21 mM trityl radical OX063 (GE Healthcare, 
Amersham, Buckinghamshire, UK) in 2:1 water:dimethyl sulfoxide  (v/v) was sonicated for 5 min at 40 ºC. 
On the day of the experiments, 1.2 mM gadoteric acid (Dotarem, Guerbet, Roissy, France) was added to 
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40 µl of the stock solution. The sample was then hyperpolarized by dynamic nuclear polarization (DNP) at 
3.35 T and 1.25 K (HyperSense, Oxford Instruments, Abingdon, UK) for approximately 80 min (build up 
time constant: 1360 ± 3 s;  polarization level: P~16% at 16 s after dissolution) and rapidly dissolved in 6 mL 
of a superheated solution of phosphate-buffered saline (neutral pH after dissolution).   
 
Hyperpolarized MR studies in vivo 
All animal studies were carried out under explicit project and personal licenses approved by the UK 
Home Office following independent ethical review. Three female C57B6 mice (weight = 20-25 g) were used 
in these experiments. To avoid changes due to circadian rhythm, the three animals were allowed to feed 
(ad libitum water and food access) during scotophase (nocturnal feed represents 75% of the total food 
intake [22]) and all MR acquisitions were performed during the first hours of the photophase, while the 
animals were still in a fed state (between 8 am and 1 pm). Each mouse was anaesthetized with 2% 
isoflurane/oxygen mixture and a tail-vein cannula inserted for HP [2-13C]DHAc administration. A 10-mm 
diameter 13C receive surface coil (Rapid Biomedical GMBH, Rimpar, Germany) was placed over the liver 
of the mouse, which was in a prone position, prior to moving the animal into a 7 T small-animal MR scanner 
(Agilent, Palo Alto, CA) equipped with 400 mT/m, 3000 T/m/s gradient coils and a broadband RF amplifier, 
with temperature and breathing rate monitoring.  
RF pulses were applied using a 42 mm diameter volume 1H transmit/receive and 13C transmit coil 
(Rapid Biomedical GMBH, Rimpar, Germany), and the 13C signal recorded through the 10-mm 13C surface 
coil. Sagittal, coronal and axial T2-weighted 1H MR images were acquired for anatomical reference and to 
confirm the positioning of the surface coil. A slice selective pulse acquire 1H-sequence was used to 
manually shim the 8 mm spatial slice of the 13C acquisition. Localized, 1H-decoupled, dynamic 13C-MR 
spectra were acquired from 20 s after the beginning of the injection of HP [2-13C]DHAc (400 µl of 54 mM 
DHAc solution injected over 3 s, ~10 s after dissolution), using a series of three consecutive SPSP RF 
pulse-acquisitions (Fig. 3A). Inverse-gated 1H-decoupling was applied only during signal acquisition (Waltz 
16, 0.235 Gauss). Acquisition parameters included: repetition time for dynamic acquisition = 1 s; receiver 
bandwidth = 10 kHz; number of points = 2048; # scans at each acquisition frequency = 9; nominal flip angle 
pulse #1 = 15º at the DHAc resonance, nominal flip angle pulse #2 = 90º, nominal flip angle pulse #3 = 90º. 
 
Data processing and statistical analysis 
Data processing was performed in MATLAB® (TheMathworks Inc., Natick, MA, USA). A 23 Hz 
gaussian line broadening was applied prior to Fourier transformation. Each real spectrum was then 
corrected for phase, baseline and baseline offset. The first 6 spectra for each frequency range were 
summed. The areas under the spectral peaks of interest were calculated by integration and normalized to 
the [2-13C]DHAc integral to minimize variations due to [2-13C]DHAc polarization, concentration, volume of 
infusion, tracer delivery, and coil loading and placement [11]. Average data are shown as mean ± standard 
deviation for the 3 animals. 
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Estimated metabolite-to-substrate ratios were calculated at t = 20 s based on the ex vivo results and 
model of Kirpich et al. [23] The rate constants and relaxation time constants included in the model were not 
adjusted for field strength or in vivo conditions. Details on the simulations are given as supporting 
information in S1. Briefly, a gamma function (equation 11 in reference [23]) was used, with α=1 and β=1, 
and the time courses of the 14 metabolites included in the model were simulated with an ordinary differential 
equation solver at t = 20 s. This was then repeated with α=2/ β=2 and α=3/β=3 to generate the data in Fig. 
S1, showing that for many metabolite ratios the input function does not perturb the result greatly. The 
simulation is again repeated with α=1/β=1 and 11 values of k drawn randomly from a normal distribution 
with the mean and standard deviation values from Kirpich et al. [23] This is repeated 1000 times with any 
negative values of rate constants discarded and replaced. The mean (bar value) and standard deviation 
(error bar) from these 1000 simulations are plotted as the modelled data in Fig. 4.  
 
RESULTS 
The RF and magnetic field gradient waveforms, and RF excitation spectral-spatial profiles of the 
resulting three purpose-designed SPSP RF pulses are shown in Fig. 2A-F. ‘Pulse #1’ (10.44 ms) excited 
the [2-13C]DHAc resonance at 214 ppm; ‘pulse #2’ (10.18 ms) the  PEP resonance at 150.5 ppm; and ‘pulse 
#3’ (2.98 ms) excited other metabolites of interest at around 72 ppm and 50 ppm – namely C5-β-glucose-
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6-phosphate (G6P-C5), C2-3-phosphoglycerate (3PG-C2), C2-β-glucose (Glc-C2), C2-β-glucose-6-
phospate (G6P-C2), C2-glyceraldehyde 3-phosphate (Ga3P-C2), C2-glycerol (Gly-C2), C2-glycerol-3-
phosphate (G3P-C2), C2-lactate (Lac-C2) and C2-alanine (Ala-C2).  
Representative 1H-decoupled 13C-MR spectra acquired sequentially in vivo 20 s after tail vein injection 
of HP [2-13C]DHAc across the three separate spectral regions are shown in Fig. 3B-D. Positioning of the 
receiver coil is shown in Fig. 3E and 3F and the full spectral ranges acquired for each spectrum are 
displayed in Fig. S2. 1H-decoupling collapsed the G3P-C2 and Ga3P-C2 resonance doublets into singlets 
and also improved the resolution of smaller signals, such as glucose, G6P, lactate-C2 and alanine-C2. The 
resonances observed following pulse #3 (Fig. 3D) were assigned by reference to a previous study 
performed in perfused livers in a glycogenolytic state [10], where the same resonances were observed after 
the infusion of hyperpolarized [2-13C]DHAc. 
The integrals of the metabolite peaks observed in Fig. 3B-D were calculated. The integrals of the C2-
β-glucose (Glc-C2), C2-β-glucose-6-phosphate (G6P-C2), C5-β-glucose-6-phosphate (G6P-C5) and C2-3-
phosphoglycerate (3PG-C2) resonances, which were not well resolved, were added together to give a 
collective value for the hexoses. Table 1 summarizes the in vivo metabolite-to-substrate ratios obtained in 
the three mice (the spectra from which these ratios were obtained are displayed in Fig. S3). 
 
Fig. 2 Radiofrequency (blue; G) and magnetic field gradient (red; G/cm) profiles of the spectral-spatial RF 
pulses used to excite dihydroxyacetone (DHAc) (A), phosphoenolpyruvate (PEP) (B) and other 
metabolites of interest (C). Simulations of their frequency and spatial profiles, shown as transverse 
magnetization, for the three pulses are shown in: (D) DHAc, (E) PEP and (F) the other metabolites of 
interest. (G) A chemical shift axis showing the regions of the spectrum that are excited by the spectral-
spatial pulses. 
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  Ala G3P Gly Ga3P Lac Hex PEP 
Metabolite  
Ratio ± SD 
0.0038± 
0.0015 
0.0605± 
0.0200 
0.0009± 
0.0005 
0.0102± 
0.0016 
0.0018± 
0.0001 
0.0070± 
0.0035 
0.0199± 
0.0040 
Table 1. Metabolite-to-[2-13C]DHAc signal intensity ratios (n=3). Abbreviations: Ala = alanine, G3P = 
glycerol-3-phosphate, Gly = glycerol, Ga3P = glyceraldehyde 3-phosphate, Lac = lactate, Hex = 
hexoses, PEP = phosphoenolpyruvate.  
Fig. 3 Acquisition scheme and spectra acquired from the liver of a mouse infused with hyperpolarized 
[2-13C]dihydroxyacetone (DHAc). A) Three spectral regions were acquired in an interleaved fashion. B) 
Spectrum showing DHAc resonance at 212.9 ppm (acquired using pulse #1). C) Spectrum (x10 vertical 
scale relative to (B)) showing the phosphoenolpyruvate (PEP) resonance (acquired using pulse #2). D) 
Spectrum (x10 vertical scale relative to (B)) showing resonances from C5-β-glucose-6-phosphate (G6P-
C5), C2-3-phosphoglycerate (3PG-C2), C2-β-glucose (Glc-C2), C2-β-glucose-6-phosphate (G6P-C2), 
C2- glyceraldehyde 3-phosphate (Ga3P), C2-glyceraldehyde-3-phosphate (Ga3P-C2), C2 -glycerol 
(Gly-C2), C2-glycerol-3-phosphate (G3P-C2), C2-lactate (Lac-C2) and C2-alanine (Ala-C2) (acquired 
using pulse #3). (E & F) T2-weighted images of the mouse (84x42 mm 512x256 data points, fast-spin-
echo; effective echo time 25 ms; repetition time 1.5 s). The location and orientation of the 10-mm receive 
coil is represented by the bold white line and the 8 mm thick acquisition slice is indicated by the dotted 
lines. 
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The metabolite-to-substrate ratios measured in vivo at 20 s after injection of hyperpolarized 
[2-13C]DHAc were compared with those estimated at the same time point from the ex vivo results obtained 
in perfused livers (Fig. 4) [23]. The estimated ratios are relatively insensitive to the shape of the input 
function, except for lactate-C2 (see Fig. S1).  In some cases, the ratios were similar, including the ratio for 
the combined hexose resonances (mostly glucose and G6P).  However, the Ga3P signal was slightly 
greater than half the expected amplitude estimated from the ex vivo data while the lactate and alanine ratios 
were very different between the two studies. 
 
 
Fig. 4 Ratio of metabolite peak areas to that of dihydroxyacetone (DHAc) 20 s after the injection of a 
bolus of the hyperpolarized 13C-labeled substrate. The mean ratio is shown in grey with the standard 
deviation indicated by an error bar. The diagonal striped bars indicate the calculated ratios at 20 s mark 
after the start of DHAc infusion based on the analysis described by Kirpich et al. [23] 
 
DISCUSSION 
We have demonstrated that hyperpolarized [2-13C]DHAc enables simultaneous detection of 
intermediates in gluconeogenesis, glycolysis and glycerol synthesis in vivo with a spectral resolution and 
sensitivity similar to that reported in perfused mouse liver [10]. To achieve this, excitation was performed 
using a train of optimized SPSP RF pulses and 13C acquisition with broadband 1H-decoupling. A SPSP RF 
pulse had been used previously at 3 T to excite the broad spectrum of interest (> 144 ppm), while minimizing 
excitation of DHAc and preserving magnetization of the metabolites beyond DHAP [18].  With the higher 
field used here (7 T), and thus greater spectral dispersion of the metabolite resonances, it was possible to 
use three sequential SPSP RF pulses to excite three distinct spectral regions. The 10 mm surface coil 
placed directly over the liver and the SPSP RF pulses ensured that the excited and observed volumes 
resided within the liver and its associated vasculature. 
A potential concern related to the application of 1H decoupling during in vivo 13C MR acquisitions is 
local tissue heating. However, specific absorption rates (SAR) can be taken into account during the RF 
pulse and coil design. Decoupling schemes have been implemented previously in human studies [24]. Here, 
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conventional broadband 1H-decoupling was applied exclusively during acquisition and nuclear Overhauser 
effect (NOE) enhancement from 1H to 13C was therefore avoided.  
Following injection of HP [2-13C]DHAc, the metabolic products observed with highest SNR were G3P, 
Ga3P, PEP and alanine. As in the previous studies performed in vivo at 3 T [11] and in the perfused liver 
at 9.4 T [10], it was not possible to resolve the DHAP resonance from the large substrate signal. 
A single HP [2-13C]DHAc injection was given to each animal and, as has been shown previously in 
rats using a glucometer blood reading [11], we assume that this does not perturb circulating glucose levels. 
The ratio of labeled 3-carbon metabolites (G3P, Ga3P, PEP, Lac, Ala, Gly) to hexoses was 14.9 ± 3.2, 
which indicates higher glycolytic than gluconeogenic activity. This agrees with a study where hepatocytes 
harvested from fed rats incubated with DHAc showed that ~90% of the total DHAc was converted into the 
downstream metabolites of glycolysis, and only ~10% was converted into glucose [25]. 
The acquisition method used here was different from that used in the previous ex vivo studies:   1) the 
field strength was higher – which may affect some of the metabolite T1s and T2s – and 2) in vivo we used 
a bolus of DHAc rather than a 4 mM infusion over 90 s [10]. This difference in the delivery of the substrate 
was necessary to optimize the SNR in the in vivo (7 T) experiment. The spectra of fed mouse liver in vivo 
observed here are remarkably similar to those observed ex vivo despite the differences in the experimental 
protocols. Although the data-sets are significantly different for each metabolite ratio measured and 
simulated, the similarities in relative metabolite amounts are striking given the expected errors in the 
acquired data and the modelling. Variations between the in vivo and ex vivo datasets are most likely due 
to differences in the bolus injection of [2-13C]DHAc, which could lead to saturation of transporters or 
enzymes in vivo, and changes in the relative flux through the pathways. For example, the Ga3P-to-DHAc 
ratio measured in vivo was lower than in perfused liver, which will be highly dependent on the relative 
activities of triose phosphate isomerase and G3P dehydrogenase (which is dependent on NADH and 
therefore redox status). It is likely that the flux from DHAc to Ga3P is lower in the in vivo experiment due to 
differing experimental conditions. In contrast, the alanine-to-lactate ratio of 2.2±0.9 was substantially higher 
in the in vivo experiments as compared to the previous studies in perfused liver, where it was less than 1 
[26],[27], suggesting greater alanine transaminase activity in vivo or reduced lactate dehydrogenase activity 
ex vivo caused by lower NADH concentration. It should be noted that the implementation of the model - 
here in these simulations – leads lactate and alanine amounts to be highly dependent on the input function 
used, increasing their variability at a simulated 20 s time point.  
Under physiological conditions, gluconeogenesis and glycolysis are balanced according to the 
metabolic state of the liver such that one dominates over the other according to need. Despite this, imaging 
with a surfeit of DHAc (the concentration of DHAc in normal liver is 13 µmoles/kg in rats [28]) shows the 
capacity of at least parts of these metabolic processes to occur simultaneously. 
The limited SNR restricted the present study to a static snapshot of liver metabolism and it was 
therefore not possible to use kinetic models to analyze the data, unlike in the perfused liver study [23]. 
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Future efforts should focus on higher hyperpolarization levels, a faster and automated injection method 
[29], and larger animal models to allow dynamic and spatial measurements. 
 
To conclude, we have demonstrated that hyperpolarized [2-13C]DHAc can be used to probe triglyceride-
precursor synthesis and glucose metabolism in real time in the liver in vivo using a combination of 1H-
decoupling and SPSP RF pulses. This protocol should further enable changes in glucose metabolism to be 
investigated non-invasively in different metabolic states, including those caused by cancer and NAFLD. For 
example, Changani et al. reported that patients with cirrhotic liver showed reduced gluconeogenesis from 
alanine using 31P-MR spectroscopy [30]. Similarly, reduced conversion of HP DHAc into glucose should 
indicate hepatocyte cell-loss or function-loss and also localize the region affected for biopsy. If so, HP DHAc 
may prove a sensitive test for pre-cancerous and cancer lesions. 
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